| mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
| mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
| mRNA |
IOX2 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.002 |
| mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
| mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
| mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.003 |